Rainbow Children's Medicare Past Earnings Performance
Past criteria checks 4/6
Rainbow Children's Medicare has been growing earnings at an average annual rate of 33.9%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 17.3% per year. Rainbow Children's Medicare's return on equity is 19.3%, and it has net margins of 17.3%.
Key information
33.9%
Earnings growth rate
31.8%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 17.3% |
| Return on equity | 19.3% |
| Net Margin | 17.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)
Nov 07
Recent updates
Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio
Mar 20Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up
Feb 13Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?
Jan 18Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)
Nov 07Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors
Oct 18A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)
Aug 29With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case
Jul 08Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 18Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely
Feb 11Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?
Sep 20Revenue & Expenses BreakdownBeta
How Rainbow Children's Medicare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 12,728 | 2,196 | 3,280 | 0 |
| 30 Sep 23 | 12,432 | 2,154 | 3,244 | 0 |
| 30 Jun 23 | 12,236 | 2,136 | 3,155 | 0 |
| 31 Mar 23 | 11,736 | 2,108 | 3,018 | 0 |
| 31 Dec 22 | 10,691 | 1,690 | 731 | 0 |
| 30 Sep 22 | 10,114 | 1,560 | 530 | 0 |
| 30 Jun 22 | 9,646 | 1,405 | 2,055 | 0 |
| 31 Mar 22 | 9,738 | 1,378 | 2,268 | 0 |
| 31 Dec 21 | 9,252 | 1,269 | 202 | 0 |
| 30 Sep 21 | 8,528 | 972 | 169 | 0 |
| 30 Jun 21 | 7,415 | 642 | 643 | 0 |
| 31 Mar 21 | 6,500 | 400 | 123 | 0 |
| 31 Mar 20 | 7,194 | 549 | 172 | 0 |
| 31 Mar 19 | 5,428 | 443 | 129 | 0 |
Quality Earnings: RAINBOW has high quality earnings.
Growing Profit Margin: RAINBOW's current net profit margins (17.3%) are higher than last year (15.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RAINBOW's earnings have grown significantly by 33.9% per year over the past 5 years.
Accelerating Growth: RAINBOW's earnings growth over the past year (30%) is below its 5-year average (33.9% per year).
Earnings vs Industry: RAINBOW earnings growth over the past year (30%) exceeded the Healthcare industry 29.5%.
Return on Equity
High ROE: RAINBOW's Return on Equity (19.3%) is considered low.